March 2022

NEUROSCIENCES

RARE CENTRAL NERVOUS SYSTEM TUMORS: PROGRESS IN CLINICAL CARE AND RESEARCH

Featuring: Rimas V. Lukas, MD

Episode Summary

The Lou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital is a nationally recognized leader in the fight against brain and spinal cord tumors. It offers patients individualized, compassionate care and the most advanced clinical trial and treatment options available. Rimas V. Lukas, MD, a member of Lurie Cancer Center and associate professor of Neurology in the Division of Neuro-oncology at Northwestern Medicine, joins the latest episode of the Better Edge podcast to discuss some of those options for patients with rare central nervous system (CNS) tumors. He talks about exciting research on the potential benefits of immunotherapy and the use of leading-edge technologies, including DNA methylation profiling, for diagnosis. Dr. Lukas also discusses some of the CNS specialized programs offered at Northwestern Medicine, such as the low-grade glioma program, Von Hippel-Lindau disease program and chordoma program.
Rimas V. Lukas, MD, is a member of Lurie Cancer Center and associate professor of Neurology in the Division of Neuro-oncology at Northwestern Medicine.

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you on the care of your patients.

You May Also Like